ArticleProceedings of the National Academy of Sciences of the United States of America1997

A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers.

K Szepeshazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.